Hepln-13

• CAT Number: I012577
• CAS Number: 64369-13-7
• Molecular Formula: C17H13BrN2
• Molecular Weight: 325.209
• Purity: ≥95%
• Synonyms: 2-(4-Bromo-phenyl)-2,3-dihydro-1H-perimidine
• IUPAC Name: 2-(4-bromophenyl)-2,3-dihydro-1H-perimidine
• InChI: InChI=1S/C17H13BrN2/c18-13-9-7-12(8-10-13)17-19-14-5-1-3-11-4-2-6-15(20-17)16(11)14/h1-10,17,19-20H
• InChIKey: YSRRRCGJBGQBDM-UHFFFAOYSA-N
• SMILES: C1=CC2=C3C(=C1)NC(NC3=CC=C2)C4=CC=C(C=C4)Br

Hepln-13(CAT: I012577) is a potent and orally active inhibitor of the protease enzyme Hepsin. Hepsin is a type II transmembrane serine protease that plays a role in various physiological processes, including cell signaling, cell adhesion, and tissue remodeling. Hepln-13 works by selectively targeting and inhibiting the activity of Hepsin, disrupting its function and downstream signaling pathways. Its pharmacologic action may have potential therapeutic applications in cancer treatment and other diseases where Hepsin is involved in disease progression.